Dietary Supplement
Oncoxin-Viusid
Oncoxin-Viusid is a dietary supplement with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
4
100%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 24 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.
NCT03540407
completedphase_2
Evaluation of Oncoxin-Viusid® in Prostate Cancer
NCT03543670
completedphase_2
Evaluation of Oncoxin-Viusid® in Head and Neck Cancer
NCT03541772
completedphase_2
Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma
NCT03541148
Clinical Trials (4)
Showing 4 of 4 trials
NCT03540407Phase 2
Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.
NCT03543670Phase 2
Evaluation of Oncoxin-Viusid® in Prostate Cancer
NCT03541772Phase 2
Evaluation of Oncoxin-Viusid® in Head and Neck Cancer
NCT03541148Phase 2
Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma
All 4 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 4